Jean-Pierre Benitah Selected Research

Bidirectional tachycardia

1/2024

Dual effect of cardiac FKBP12.6 overexpression on excitation-contraction coupling and the incidence of ventricular arrhythmia depending on its expression level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Pierre Benitah Research Topics

Disease

11	Heart Failure 01/2022 - 07/2004
8	Cardiomegaly (Heart Hypertrophy) 01/2024 - 08/2004
5	Cardiac Arrhythmias (Arrythmia) 01/2024 - 10/2007
4	Hypertrophy 07/2013 - 08/2004
3	Myocardial Infarction 01/2022 - 07/2004
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 10/2018
2	Cardiotoxicity 01/2023 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 11/2021
2	Hypertension (High Blood Pressure) 01/2022 - 10/2007
2	Fibrosis (Cirrhosis) 11/2021 - 01/2018
2	Sudden Death 10/2018 - 08/2004
2	Polymorphic catecholergic ventricular tachycardia 07/2012 - 01/2009
1	Bidirectional tachycardia 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Hypoxia (Hypoxemia) 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	Diabetic Cardiomyopathies 11/2021
1	Atrial Fibrillation 01/2021
1	Sick Sinus Syndrome 01/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2018
1	Long QT Syndrome 10/2018
1	Pulmonary Hypertension 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Right Ventricular Hypertrophy 01/2018
1	Heart Diseases (Heart Disease) 10/2015
1	Chronic Disease (Chronic Diseases) 10/2007
1	Atherosclerosis 10/2007
1	Atrial Remodeling 08/2004
1	Infarction (Infarctions) 07/2004

Drug/Important Bio-Agent (IBA)

5	erythromycin propionate-N-acetylcysteinateIBA 01/2023 - 11/2012
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2013
4	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022 - 01/2012
4	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 06/2016 - 07/2004
3	CalcineurinIBA 01/2024 - 01/2012
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2024 - 11/2012
3	CalciumIBA 11/2021 - 07/2020
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 01/2009
3	AldosteroneIBA 01/2018 - 07/2004
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 07/2013 - 01/2012
2	AnthracyclinesIBA 01/2023 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2019
2	MonocrotalineIBA 10/2022 - 01/2018
2	MineralocorticoidsIBA 12/2019 - 04/2009
2	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 07/2004
2	EnzymesIBA 07/2013 - 01/2012
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 07/2013 - 01/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2013 - 01/2012
1	tacrolimus binding protein 1BIBA 01/2024
1	Caffeine (No Doz)FDA LinkGeneric 01/2024
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2024
1	aniline (aniline hydrobromide)IBA 10/2022
1	ThiadiazolesIBA 10/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	junctophilinIBA 01/2022
1	SaltsIBA 01/2022
1	Calcium Channels (Calcium Channel)IBA 01/2022
1	Cardiac MyosinsIBA 01/2022
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2022
1	HexosaminesIBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	sarcolipinIBA 07/2020
1	LaminsIBA 07/2020
1	Amino Acids FDA Link 10/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	LeptinIBA 01/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2013
1	Protein Kinases (Protein Kinase)IBA 11/2012
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2012
1	Hormones (Hormone)IBA 10/2007
1	GlucocorticoidsIBA 10/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2004
1	Interleukin-6 (Interleukin 6)IBA 07/2004
1	Messenger RNA (mRNA)IBA 07/2004

Therapy/Procedure

2	Therapeutics 11/2021 - 07/2020
1	Intravenous Infusions 01/2018